Cited by 48Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Molecular mechanisms of the genetic risk factors in pathogenesis of Alzheimer disease

Tomita, Taisuke·2017·Frontiers in Bioscience

Abstract

Alzheimer disease (AD) is a neurodegenerative disease characterized by the extensive deposition of senile plaques and neurofibrillary tangles. Until recently, only the APOE gene had been known as a genetic risk factor for late-onset AD (LOAD), which accounts for more than 95% of all AD cases. However, in addition to this well-established genetic risk factor, genome-wide association studies have identified several single nucleotide polymorphisms as genetic risk factors of LOAD, such as PICALM and BIN1. In addition, whole genome sequencing and exome sequencing have identified rare variants associated with LOAD, including TREM2. We review the recent findings related to the molecular mechanisms by which these genetic risk factors contribute to AD, and our perspectives regarding the etiology of AD for the development of therapeutic agents.

Integrity signals

Registry

Crossref · 10.2741/4480

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Still being checked.

Cited by

Sorted by citations

Authors
Tomita, T.
Affiliations
The University of Tokyo (JP)
Corresponding author
Tomita, Taisuke
Venue
Frontiers in Bioscience
Publisher
IMR Press
Published
2017
Volume
22
Issue
1
Pages
180-192
ISSN
  • 1093-4715 (ISSN-L)
  • 1093-9946
OpenAlex
W2548785077
Cited by
48
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 30 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 4
FWCI
1.88
Type
journal article
Language
en
Open access
closed
Locations
  • Frontiers in bioscience (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, late-onset Alzheimer's disease, genetic risk factors, apolipoprotein E, single nucleotide polymorphisms, PICALM, BIN1, TREM2, rare variants, amyloid plaques, neurofibrillary tangles, pathogenesis, therapeutic target
MeSH terms
Alzheimer Disease, Humans, Membrane Glycoproteins, Mutation, Receptors, Immunologic, Risk Factors, Amyloid beta-Peptides, Genetic Predisposition to Disease, Membrane Transport Proteins, Lipid Metabolism, Apolipoprotein E4, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review